Sarilumab, a biologic, is sold as Kevzara. The FDA recently approved sarilumab (Kevzara) for the treatment of adults with polymyalgia rheumatica (PMR) who had an inadequate response to corticosteroids ...

Discover comprehensive details about Sarilumab, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Please provide your email address to receive an email when new articles are posted on . “If providers treating PMR are having difficulty tapering people off steroids without concomitant ...

More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be clinically useful in ...

Please provide your email address to receive an email when new articles are posted on . Patients were more likely to achieve sustained remission with sarilumab vs. placebo. The most common adverse ...

PHILADELPHIA — Treatment with the interleukin-6 receptor antagonist sarilumab (Kevzara), along with a 14-week taper of glucocorticoids, proved to have significant efficacy in patients with relapsing ...

Review the side-effects of Sarilumab as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The appraisal committee considered evidence submitted by Sanofi and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the evidence. Sarilumab ...

Credit: Shutterstock. Patients in the sarilumab vs placebo group achieved sustained remission of polymyalgia rheumatica at higher rates. Sarilumab demonstrates significant efficacy and is safe in the ...

Patients with rheumatoid arthritis receiving sarilumab have lower odds of unacceptable pain and are able to reduce their dose of oral glucocorticoid; they also have lower costs per responder than most ...

SanofiSNY came up with important announcements on both the deal making and pipeline front. Partnership Extended with Warp Drive Bio Sanofi and a privately held biotech company, Warp Drive Bio, ...

The committee concluded that sarilumab plus methotrexate is more clinically effective than placebo plus methotrexate, and that sarilumab alone is more clinically effective than adalimumab alone for ...